51 related articles for article (PubMed ID: 3937951)
1. Ambroxol lozenge bioavailability : an open-label, two-way crossover study of the comparative bioavailability of ambroxol lozenges and commercial tablets in healthy thai volunteers.
Rojpibulstit M; Kasiwong S; Juthong S; Phadoongsombat N; Faroongsarng D
Clin Drug Investig; 2003; 23(4):273-80. PubMed ID: 17535040
[TBL] [Abstract][Full Text] [Related]
2. Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: double-blind Italian multicenter clinical study versus placebo.
Fegiz G
Lung; 1991; 169(2):69-76. PubMed ID: 1688356
[TBL] [Abstract][Full Text] [Related]
3. Ambroxol for prevention and treatment of hyaline membrane disease.
Wauer RR; Schmalisch G; Hammer H; Buttenberg S; Weigel H; Huth M
Eur Respir J Suppl; 1989 Mar; 3():57S-65S. PubMed ID: 2662997
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant.
Heath MF; Jacobson W
Lung; 1985; 163(6):337-44. PubMed ID: 3937951
[No Abstract] [Full Text] [Related]
5. Incorporation of palmitate into pulmonary surfactant under influence of Ambroxol.
Elemer G; Kapanci Y
Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():723-4. PubMed ID: 6689071
[No Abstract] [Full Text] [Related]
6. The perfused rat lung as a model for studies on the formation of surfactant and the effect of Ambroxol on this process.
Post M; Batenburg JJ; Schuurmans EA; Oldenborg V; van der Molen AJ; van Golde LM
Lung; 1983; 161(6):349-59. PubMed ID: 6689042
[No Abstract] [Full Text] [Related]
7. Increased incorporation of fatty acids into phospholipids of lungs and livers of rabbits under the influence of bromhexine and ambroxol.
von Wichert P; Bavendamm U; von Teichmann M; Müller G; Thalheim E; Wilke A; Wiegers U
Naunyn Schmiedebergs Arch Pharmacol; 1977 Apr; 297(3):269-73. PubMed ID: 876401
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis of water-soluble metabolites of cholin and incorporation of choline in phosphatidylcholine in the lungs of normal and ambroxol-pretreated rabbits].
Reissmann H; Wiegers U; Meyer-Ingold W; von Wichert P
Prax Klin Pneumol; 1984 Mar; 38(3):104-7. PubMed ID: 6326074
[No Abstract] [Full Text] [Related]
9. [Ambroxol and stimulation of the pulmonary surfactant].
Zavattini G
Acta Otorhinolaryngol Ital; 1987; 7 Suppl 16():33-8. PubMed ID: 3334302
[No Abstract] [Full Text] [Related]
10. The nature of the phospholipases A of lung lamellar bodies.
Heath MF; Jacobson W
Pediatr Res; 1980 Jun; 14(6):846-7. PubMed ID: 7402758
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C.
Hostetler KY; Matsuzawa Y
Biochem Pharmacol; 1981 May; 30(10):1121-6. PubMed ID: 7259794
[No Abstract] [Full Text] [Related]
12. Accumulation of weak bases in relation to intralysosomal pH in cultured human skin fibroblasts.
Hollemans M; Elferink RO; De Groot PG; Strijland A; Tager JM
Biochim Biophys Acta; 1981 Apr; 643(1):140-51. PubMed ID: 7236683
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone pulmonary toxicity.
Marchlinski FE; Gansler TS; Waxman HL; Josephson ME
Ann Intern Med; 1982 Dec; 97(6):839-45. PubMed ID: 7149492
[TBL] [Abstract][Full Text] [Related]
14. Influence of transplacental NA-872 and dexamethasone therapy on fetal and newborn mouse lung.
Velásquez BJ; Sepúlveda J
Respiration; 1982; 43(5):389-400. PubMed ID: 7146641
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
